|
![]() |
|||
|
||||
Overview'Clinical mycology is an area of rapid advances and changing perspectives and so it is encouraging to see this new comprehensive text covering this field... The volume is an excellent place of reference and is well written throughout... this is a very useful volume indeed to have in the library or on the laboratory reference shelf.' -Microbiology Today, Vol 31Within the field of infectious diseases, medical mycology has experienced significant growth over the last decade. Invasive fungal infections have been increasing in many patient populations, including: those with AIDS; transplant recipients; and the elderly. As these populations grow, so does the diversity of fungal pathogens. Paralleling this development, there have been recent launches of several new antifungal drugs and therapies. Clinical Mycology offers a comprehensive review of this discipline. Organized by types of fungi, this volume covers microbiologic, epidemiologic and demographic aspects of fungal infections as well as diagnostic, clinical, therapeutic, and preventive approaches. Special patient populations are also detailed.Readership: Infectious disease specialists and mycologists Full Product DetailsAuthor: William E. Dismukes , Peter G. Pappas , Dr. Jack D. Sobel , William E. DismukesPublisher: Oxford University Press Inc Imprint: Oxford University Press Inc Dimensions: Width: 22.30cm , Height: 3.50cm , Length: 28.70cm Weight: 1.503kg ISBN: 9780195148091ISBN 10: 0195148096 Pages: 560 Publication Date: 01 September 2003 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsPreface ; PART I: INTRODUCTION ; 1. Laboratory Aspects of Medical Mycology ; 2. Epidemiology of Systemic Fungal Diseases: Overview ; PART II: SYSTEMIC ANTIFUNGAL DRUGS ; 3. Amphotericin ; 4. Liposomal Nystatin ; 5. Flucytosine ; 6. Azole Antifungal Drugs ; 7. Cell Wall Synthesis Inhibitors: Echinocandins and Nikkomycins ; 8. Terbinafine ; 9. Resistance to Antifungal Drugs ; 10. Adjunctive Antifungal Therapy ; PART III: MYCOSES CAUSED BY YEASTS ; 11. Candidiasis ; 12. Cryptococcosis ; 13. Rhodotorula, Malassazia, Trichosporon, and Other Yeast-like Fungi ; PART IV: MYCOSES CAUSED BY MOULDS ; 14. Aspergillosis ; 15. Zygomycoses ; 16. Hyalohyphomycoses (other than Aspergillosis and Penicilliosis) ; 17. Phaeophyphomycosis ; PART V: MYCOSIS CAUSED BY DIMORPHIC FUNGI ; 18. Histoplasmosis ; 19. Blastomycosis ; 20. Coccidioidomycosis ; 21. Paracoccidioidomycosis ; 22. Sporotrichosis ; 23. Penicilliosis ; PART VI: MYCOLOGY INVOLVING SKIN AND SUBCUTANEOUS TISSUES ; 24. Superficial Cutaneous Fungal Infections ; 25. Eumycetoma ; 26. Chromoblastomycosis ; PART VII: OTHER MYCOSES ; 27. Pneumocystosis ; 28. Miscellaneous Fungi ; PART VIII: SPECIAL PATIENT POPULATIONS ; 29. Fungal Infections in Neutropenic Patients ; 30. Fungal Infections in Blood or Marrow Transplant Recipients ; 31. Fungal Infections in Solid Organ Transplant Recipients ; 32. Fungal Infections among Patients with AIDSReviewsClinical mycology is an area of rapid advances and changing perspectives and so it is encouraging to see this new comprehensive text covering this field ... The volume is an excellent place of reference and is well written throughout ... this is a very useful volume indeed to have in the library or on the laboratory reference shelf. Microbiology Today, Vol 31 Author InformationTab Content 6Author Website:Countries AvailableAll regions |